SBFM FY 2020 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$71,410+238.1% YoY

Gross Profit

$45,56363.8% margin

Operating Income

-$576,874-807.8% margin

Net Income

-$3M-3898.7% margin

EPS (Diluted)

$-3214.89

Cash Flow

Operating Cash Flow

-$657,299

Free Cash Flow

-$658,490

Stock-Based Comp.

$50,000

Balance Sheet

Total Assets

$1M

Total Liabilities

$2M

Stockholders' Equity

-$954,837

Cash & Equivalents

$989,888

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71,410	$21,121	+238.1%
Gross Profit	$45,563	$10,071	+352.4%
Operating Income	-$576,874	-$641,636	+10.1%
Net Income	-$3M	-$2M	-67.7%